Doxycycline added to a chest drain for cancer fluid buildup
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial studies whether adding an antibiotic called doxycycline to an indwelling chest drain improves symptoms and fluid control in people with cancer-related fluid around the lungs. It’s mainly for patients who are getting this drain placed and can complete brief symptom check-in questions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer fluid around the lung (malignant pleural effusion) and are getting a drainage catheter placed
- You can understand the study, consent, and answer symptom questions by phone or in clinic
- If you’re an inpatient, you’re expected to go home within 5 days after the catheter is placed
- You are not pregnant
- You have not already had the same-side “inside-the-chest” treatment with doxycycline or similar medicine before
- Your doctor says doxycycline is safe for you (no allergy) and your fluid buildup isn’t in a pattern that blocks treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies specific markers (biomarkers) found in fluid from a chest drain to better understand pleural effusions (fluid around the lungs), especially when fluid keeps coming back after treatment. You may be helped by contributing to research that could improve how these effusions are diagnosed and managed.
This trial compares two ways to drain fluid from the chest when it collects in pockets and is caused by inflammation or infection. It uses a thin tube placed with ultrasound guidance, and the goal is to see which method works better.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
This trial tests a new device to wash out fluid that stays in the chest after a chest tube is placed. It might help people who cannot receive standard medication to break up this fluid within the first day after their chest tube is inserted.
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
This trial is testing a small chest tube drainage method for people with fluid buildup around the lung. It may help prevent the fluid from returning, especially if you have a condition like cancer.
Hear when a new Pleural Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.